Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a sponsor or operator at the GP level to capitalize on the ongoing demand for specialized facilities.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor/operator at the GP level, capitalizing on the significant venture capital and NIH funding available.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a proven operator in San Francisco or Raleigh-Durham, sharing in the promote and benefiting from their established pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a reputable operator to co-GP on lab space developments, leveraging their expertise and access to a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Houston life sciences market by backing a sponsor/operator focused on biopharmaceutical manufacturing to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in managing lab assets, particularly in high-demand areas like San Diego and San Francisco.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests with those who have a strong pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with established operators to co-GP on projects that leverage academic and medical partnerships.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator focused on developing biotech incubators or educational partnerships to share in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor or operator at the GP level, particularly those involved in the recent leasing activity and development projects.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor/operator at the GP level to capitalize on the anticipated recovery in venture funding and M&A activity.

Co-GP / Platform:A family office could deploy into the San Francisco life science market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of new developments.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor or operator at the GP level, capitalizing on the growing demand for life science facilities adjacent to healthcare ecosystems.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a local operator or sponsor at the GP level, sharing in the promote and benefiting from the area's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator at the GP level, particularly in developments like TMC Helix Park, to share in the promote and benefit from the area's strong funding environment.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in developing and managing life sciences properties, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with established operators as a co-GP, sharing in the promote and benefiting from a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, capitalizing on the ongoing development pipeline and potential for future demand.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor/operator focused on developing purpose-built lab facilities to share in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a repeatable pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests for long-term growth.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from the sector's strong funding environment.